International Clinical Trial: Investigation of Pathogenic Mechanisms Using Patient-Derived iPSC Models of Alzheimer's Disease

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131751) titled 'Investigation of Pathogenic Mechanisms Using Patient-Derived iPSC Models of Alzheimer's Disease' on Sept. 6.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Xuanwu Hospital Capital Medical University

Condition: Alzheimer's disease

Intervention: Normal Control:N/A

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-31

Target Sample Size: Normal Control:250;Alzheimer's disease:250;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=308395

Published by HT Digital Content Services with permissio...